Cardiovascular manifestations and treatment considerations in COVID-19
Top Cited Papers
Open Access
- 30 April 2020
- Vol. 106 (15), 1132-1141
- https://doi.org/10.1136/heartjnl-2020-317056
Abstract
Since its recognition in December 2019, covid-19 has rapidly spread globally causing a pandemic. Pre-existing comorbidities such as hypertension, diabetes, and cardiovascular disease are associated with a greater severity and higher fatality rate of covid-19. Furthermore, covid-19 contributes to cardiovascular complications, including acute myocardial injury as a result of acute coronary syndrome, myocarditis, stress-cardiomyopathy, arrhythmias, cardiogenic shock, and cardiac arrest. The cardiovascular interactions of covid-19 have similarities to that of severe acute respiratory syndrome, Middle East respiratory syndrome and influenza. Specific cardiovascular considerations are also necessary in supportive treatment with anticoagulation, the continued use of renin-angiotensin-aldosterone system inhibitors, arrhythmia monitoring, immunosuppression or modulation, and mechanical circulatory support.Keywords
This publication has 85 references indexed in Scilit:
- Influenza Infection and Risk of Acute Myocardial Infarction in England and Wales: A CALIBER Self-Controlled Case Series StudyThe Journal of Infectious Diseases, 2012
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005
- Fatal Severe Acute Respiratory Syndrome Is Associated with Multiorgan Involvement by CoronavirusThe Journal of Infectious Diseases, 2005
- Cytokine-Induced Modulation of Cardiac FunctionCirculation Research, 2004
- Bidirectional Relation Between Inflammation and CoagulationCirculation, 2004
- A clinicopathological study of three cases of severe acute respiratory syndrome (SARS)Pathology, 2003
- The clinical pathology of severe acute respiratory syndrome (SARS): a report from ChinaThe Journal of Pathology, 2003
- Angiotensin-converting enzyme 2 is an essential regulator of heart functionNature, 2002
- Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertensionJournal of Hypertension, 1996
- A Clinicopathological Study on Cardiac Lesions in 64 Cases of Disseminated Intravascular CoagulationJapanese Heart Journal, 1977